Literature DB >> 26038529

APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.

Wendy E Hoy1, Michael D Hughson2, Jeffrey B Kopp3, Susan A Mott4, John F Bertram5, Cheryl A Winkler6.   

Abstract

APOL1 genetic variants contribute to kidney disease in African Americans. We assessed correlations between APOL1 profiles and renal histological features in subjects without renal disease. Glomerular number (N glom) and mean glomerular volume (V glom) were measured by the dissector/fractionator method in kidneys of African-American and non-African-American adults without renal disease, undergoing autopsies in Jackson, Mississippi. APOL1 risk alleles were genotyped and the kidney findings were evaluated in the context of those profiles. The proportions of African Americans with none, one, and two APOL1 risk alleles were 38%, 43%, and 19%, respectively; 38% of African Americans had G1 allele variants and 31% of African Americans had G2 allele variants. Only APOL1-positive African Americans had significant reductions in N glom and increases in V glom with increasing age. Regression analysis predicted an annual average loss of 8834 (P=0.03, sex adjusted) glomeruli per single kidney over the first 38 years of adult life in African Americans with two risk alleles. Body mass index above the group medians, but below the obesity definition of ≥ 30 kg/m(2), enhanced the expression of age-related changes in N glom in African Americans with either one or two APOL1 risk alleles. These findings indicate that APOL1 risk alleles are associated with exaggerated age-related nephron loss, probably decaying from a larger pool of smaller glomeruli in early adult life, along with enlargement of the remaining glomeruli. These phenomena might mark mechanisms of accentuated susceptibility to kidney disease in APOL1-positive African Americans.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  APOL1 risk alleles; African Americans; glomerular enlargement; glomerular number

Mesh:

Substances:

Year:  2015        PMID: 26038529      PMCID: PMC4657832          DOI: 10.1681/ASN.2014080768

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

Review 1.  Counting in the kidney.

Authors:  J F Bertram
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

2.  APOL1 variants associate with increased risk of CKD among African Americans.

Authors:  Meredith C Foster; Josef Coresh; Myriam Fornage; Brad C Astor; Morgan Grams; Nora Franceschini; Eric Boerwinkle; Rulan S Parekh; W H Linda Kao
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

3.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

4.  End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Authors:  Barry I Freedman; Carl D Langefeld; Kelly K Andringa; Jennifer A Croker; Adrienne H Williams; Neva E Garner; Daniel J Birmingham; Lee A Hebert; Pamela J Hicks; Mark S Segal; Jeffrey C Edberg; Elizabeth E Brown; Graciela S Alarcón; Karen H Costenbader; Mary E Comeau; Lindsey A Criswell; John B Harley; Judith A James; Diane L Kamen; S Sam Lim; Joan T Merrill; Kathy L Sivils; Timothy B Niewold; Neha M Patel; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Jane E Salmon; Betty P Tsao; Keisha L Gibson; Joyce R Byers; Anna K Vinnikova; Janice P Lea; Bruce A Julian; Robert P Kimberly
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy.

Authors:  Wendy E Hoy; Rebecca N Douglas-Denton; Michael D Hughson; Alan Cass; Kelli Johnson; John F Bertram
Journal:  Kidney Int Suppl       Date:  2003-02       Impact factor: 10.545

6.  Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Josephine M Ambruzs; L Nicholas Cossey; Nidia C Messias; Patrick D Walker; Barry I Freedman
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

7.  APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.

Authors:  Xiqian Lan; Aakash Jhaveri; Kang Cheng; Hongxiu Wen; Moin A Saleem; Peter W Mathieson; Joanna Mikulak; Sharon Aviram; Ashwani Malhotra; Karl Skorecki; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-04

8.  Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.

Authors:  Carl D Langefeld; Jasmin Divers; Nicholas M Pajewski; Amret T Hawfield; David M Reboussin; Diane E Bild; George A Kaysen; Paul L Kimmel; Dominic S Raj; Ana C Ricardo; Jackson T Wright; John R Sedor; Michael V Rocco; Barry I Freedman
Journal:  Kidney Int       Date:  2014-07-16       Impact factor: 10.612

9.  Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.

Authors:  Kaoru Ito; Alexander G Bick; Jason Flannick; David J Friedman; Giulio Genovese; Michael G Parfenov; Steven R Depalma; Namrata Gupta; Stacey B Gabriel; Herman A Taylor; Ervin R Fox; Christopher Newton-Cheh; Sekar Kathiresan; Joel N Hirschhorn; David M Altshuler; Martin R Pollak; James G Wilson; J G Seidman; Christine Seidman
Journal:  Circ Res       Date:  2013-12-30       Impact factor: 17.367

10.  Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race.

Authors:  Michael D Hughson; Victor G Puelles; Wendy E Hoy; Rebecca N Douglas-Denton; Susan A Mott; John F Bertram
Journal:  Nephrol Dial Transplant       Date:  2013-12-09       Impact factor: 5.992

View more
  17 in total

Review 1.  One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.

Authors:  Jeffrey B Kopp; Avi Z Rosenberg
Journal:  Adv Anat Pathol       Date:  2019-05       Impact factor: 3.875

2.  Glomerular Effects of Age and APOL1.

Authors:  Timothy W Meyer; Colin R Lenihan
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

3.  Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

Authors:  Elaine Ku; Michael S Lipkowitz; Lawrence J Appel; Afshin Parsa; Jennifer Gassman; David V Glidden; Miroslaw Smogorzewski; Chi-Yuan Hsu
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

4.  Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume.

Authors:  Aleksandar Denic; Jerry Mathew; Venkata V Nagineni; R Houston Thompson; Bradley C Leibovich; Lilach O Lerman; John C Lieske; Mariam P Alexander; Joshua J Augustine; Walter K Kremers; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2018-05-22       Impact factor: 10.121

Review 5.  APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Authors:  Patrick D Dummer; Sophie Limou; Avi Z Rosenberg; Jurgen Heymann; George Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

6.  APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Authors:  Leslie A Bruggeman; Zhenzhen Wu; Liping Luo; Sethu M Madhavan; Martha Konieczkowski; Paul E Drawz; David B Thomas; Laura Barisoni; John R Sedor; John F O'Toole
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

7.  Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.

Authors:  Robert E Olivo; Clemontina A Davenport; Clarissa J Diamantidis; Nrupen A Bhavsar; Crystal C Tyson; Rasheeda Hall; Aurelian Bidulescu; Bessie Young; Stanford E Mwasongwe; Jane Pendergast; L Ebony Boulware; Julia J Scialla
Journal:  Nephrol Dial Transplant       Date:  2018-06-01       Impact factor: 5.992

Review 8.  Hypertension-attributed nephropathy: what's in a name?

Authors:  Barry I Freedman; Arthur H Cohen
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

Review 9.  A focus on the association of Apol1 with kidney disease in children.

Authors:  Pepe M Ekulu; Agathe B Nkoy; Oyindamola C Adebayo; Orly K Kazadi; Michel N Aloni; Fanny O Arcolino; Rene M Ngiyulu; Jean-Lambert E Gini; François B Lepira; Lamberthus P Van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2020-04-06       Impact factor: 3.714

10.  The Impact of Kidney Development on the Life Course: A Consensus Document for Action.

Authors: 
Journal:  Nephron       Date:  2017-03-21       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.